Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Diabetes Technology & Therapeutics|August 26, 2011
International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, GreeceGeremia B Bolli, Larry C Deeb, Satish K Garg, et al.
Diabetes Technology & Therapeutics|February 4, 2016
Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 DiabetesMatthew C Riddle, Geremia B Bolli, Philip D Home, et al.
Diabetes, Obesity & Metabolism|February 5, 2019
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United StatesKristina S Boye, Matthew C Riddle, Hertzel C Gerstein, et al.
Diabetes, Obesity & Metabolism|April 28, 2026
The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes MellitusGeremia B Bolli, Philip D Home, Mauro Lepore, et al.
The American Journal of Cardiology|July 12, 2007
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialHertzel C Gerstein, Matthew C Riddle, David M Kendall, et al.
Diabetes Care|February 16, 2013
Determinants of weight gain in the action to control cardiovascular risk in diabetes trialVivian Fonseca, Roberta McDuffie, Jorge Calles, et al.
The New England Journal of Medicine|June 13, 2012
Basal insulin and cardiovascular and other outcomes in dysglycemia, Hertzel C Gerstein, Jackie Bosch, et al.
The New England Journal of Medicine|June 13, 2012
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia, Jackie Bosch, Hertzel C Gerstein, et al.
Diabetes Care|February 9, 2021
Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a <i>Diabetes Care</i> Editors' Expert ForumMatthew C Riddle, Louis H Philipson, Stephen S Rich, et al.
Diabetes Care|July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker StudyHertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
Pageof 9